Cortical lesions in multiple sclerosis (MS) severely affect cognition, but their longitudinal evolution and impact on specific cognitive functions remain understudied. This study investigates the evolution of function-specific cognitive functioning over 10 years in people with MS and assesses the influence of cortical lesion load and formation on these trajectories. In this prospectively collected study, people with MS underwent 3T MRI (T1 and fluid-attenuated inversion recovery) at 3 study visits between 2008 and 2022. Cognitive functioning was evaluated based on neuropsychological assessment reflecting 7 cognitive functions: attention; executive functioning (EF); information processing speed (IPS); verbal fluency; and verbal, visuospatial, and working memory. Cortical lesions were manually identified on artificial intelligence-generated double-inversion recovery images. Linear mixed models were constructed to assess the temporal evolution between cortical lesion load and function-specific cognitive decline. In addition, analyses were stratified by MS disease stage: early and late relapsing-remitting MS (cutoff disease duration at 15 years) and progressive MS. The study included 223 people with MS (mean age, 47.8 ± 11.1 years; 153 women) and 62 healthy controls. All completed 5-year follow-up, and 37 healthy controls and 94 with MS completed 10-year follow-up. At baseline, people with MS exhibited worse functioning of IPS and working memory. Over 10 years, cognitive decline was most severe in attention, verbal memory, and EF. At baseline, people with MS had a median cortical lesion count of 7 (range 0-73), which was related to subsequent decline in attention (B[95% CI] = -0.22 [-0.40 to -0.03]) and verbal fluency (B[95% CI] = -0.23[-0.37 to -0.09]). Over time, cortical lesions increased by a median count of 4 (range -2 to 71), particularly in late and progressive disease, and was related to decline in verbal fluency (B [95% CI] = -0.33 [-0.51 to -0.15]). The associations between (change in) cortical lesion load and cognitive decline were not modified by MS disease stage. Cognition worsened over 10 years, particularly affecting attention, verbal memory, and EF, while preexisting impairments were worst in other functions such as IPS. Worse baseline cognitive functioning was related to baseline cortical lesions, whereas baseline cortical lesions and cortical lesion formation were related to cognitive decline in functions less affected at baseline. Accumulating cortical damage leads to spreading of cognitive impairments toward additional functions.

Enlarged fetal heart conditions may indicate congenital heart diseases or other complications, making early detection through prenatal ultrasound essential. However, manual assessments by sonographers are often subjective, time-consuming, and inconsistent. This paper proposes a deep learning approach using the You Only Look Once (YOLO) architecture to automate fetal heart enlargement assessment. Using a set of ultrasound videos, YOLOv8 with a CBAM module demonstrated superior performance compared to YOLOv11 with self-attention. Incorporating the ResNeXtBlock-a residual network with cardinality-additionally enhanced accuracy and prediction consistency. The model exhibits strong capability in detecting fetal heart enlargement, offering a reliable computer-aided tool for sonographers during prenatal screenings. Further validation is required to confirm its clinical applicability. By improving early and accurate detection, this approach has the potential to enhance prenatal care, facilitate timely interventions, and contribute to better neonatal health outcomes.

Chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI) has emerged as a powerful tool to image endogenous or exogenous macromolecules. CEST contrast highly depends on radiofrequency irradiation B₁ level. Spatial inhomogeneity of B₁ field would bias CEST measurement. Conventional interpolation-based B₁ correction method required CEST dataset acquisition under multiple B₁ levels, substantially prolonging scan time. The recently proposed supervised deep learning approach reconstructed B₁ inhomogeneity corrected CEST effect at the identical B₁ as of the training data, hindering its generalization to other B₁ levels. In this study, we proposed a Conditional Variational Autoencoder (CVAE)-based generative model to generate B₁ inhomogeneity corrected Z spectra from single CEST acquisition. The model was trained from pixel-wise source-target paired Z spectra under multiple B₁ with target B₁ as a conditional variable. Numerical simulation and healthy human brain imaging at 5 T were respectively performed to evaluate the performance of proposed model in B₁ inhomogeneity corrected CEST MRI. Results showed that the generated B₁-corrected Z spectra agreed well with the reference averaged from regions with subtle B₁ inhomogeneity. Moreover, the performance of the proposed model in correcting B₁ inhomogeneity in APT CEST effect, as measured by both MTR_asym and [Formula: see text] at 3.5 ppm, were superior over conventional Z/contrast-B₁-interpolation and other deep learning methods, especially when target B₁ were not included in sampling or training dataset. In summary, the proposed model allows generalized B₁ inhomogeneity correction, benefiting quantitative CEST MRI in clinical routines.

Pediatric bipolar disorder (PBD) is a highly debilitating condition, characterized by alternating episodes of mania and depression, with intervening periods of remission. Limited information is available about the functional and structural abnormalities in PBD, particularly when comparing type I with type II subtypes. Resting-state brain activity and structural grey matter, assessed through MRI, may provide insight into the neurobiological biomarkers of this disorder. In this study, Resting state Regional Homogeneity (ReHo) and grey matter concentration (GMC) data of 58 PBD patients, and 21 healthy controls matched for age, gender, education and IQ, were analyzed in a data fusion unsupervised machine learning approach known as transposed Independent Vector Analysis. Two networks significantly differed between BPD and HC. The first network included fronto- medial regions, such as the medial and superior frontal gyrus, the cingulate, and displayed higher ReHo and GMC values in PBD compared to HC. The second network included temporo-posterior regions, as well as the insula, the caudate and the precuneus and displayed lower ReHo and GMC values in PBD compared to HC. Additionally, two networks differ between type-I vs type-II in PBD: an occipito-cerebellar network with increased ReHo and GMC in type-I compared to type-II, and a fronto-parietal network with decreased ReHo and GMC in type-I compared to type-II. Of note, the first network positively correlated with depression scores. These findings shed new light on the functional and structural abnormalities displayed by pediatric bipolar patients.

Osteoarthritis (OA) is a major cause of disability worldwide, with symptoms like joint pain, limited functionality, and decreased quality of life, potentially leading to deformity and irreversible damage. Chemical changes in joint tissues precede imaging alterations, making early diagnosis challenging for conventional methods like X-rays. Although Raman imaging provides detailed chemical information, it is time-consuming. This paper aims to achieve rapid osteoarthritis diagnosis and grading using a self-developed Raman imaging system combined with deep learning denoising and acceleration algorithms. Our self-developed aberration-corrected line-scanning confocal Raman imaging device acquires a line of Raman spectra (hundreds of points) per scan using a galvanometer or displacement stage, achieving spatial and spectral resolutions of 2 μm and 0.2 nm, respectively. Deep learning algorithms enhance the imaging speed by over 4 times through effective spectrum denoising and signal-to-noise ratio (SNR) improvement. By leveraging the denoising capabilities of deep learning, we are able to acquire high-quality Raman spectral data with a reduced integration time, thereby accelerating the imaging process. Experiments on the tibial plateau of osteoarthritis patients compared three excitation wavelengths (532, 671, and 785 nm), with 671 nm chosen for optimal SNR and minimal fluorescence. Machine learning algorithms achieved a 98 % accuracy in distinguishing articular from calcified cartilage and a 97 % accuracy in differentiating osteoarthritis grades I to IV. Our fast Raman imaging system, combining an aberration-corrected line-scanning confocal Raman imager with deep learning denoising, offers improved imaging speed and enhanced spectral and spatial resolutions. It enables rapid, label-free detection of osteoarthritis severity and can identify early compositional changes before clinical imaging, allowing precise grading and tailored treatment, thus advancing orthopedic diagnostics and improving patient outcomes.

Implantation of metallic instrumentation is the mainstay of a variety of orthopaedic and spine surgeries. Postoperatively, imaging of the soft tissues around these implants is commonly required to assess for persistent, recurrent, and/or new pathology (ie, instrumentation loosening, particle disease, infection, neural compression); visualization of these pathologies often requires the superior soft-tissue contrast of magnetic resonance imaging (MRI). As susceptibility artifacts from ferromagnetic implants can result in unacceptable image quality, unique MRI approaches are often necessary to provide accurate imaging. In this text, a comprehensive review is provided on common artifacts encountered in orthopaedic MRI, including comparisons of artifacts from different metallic alloys and common nonpropriety/propriety MR metallic artifact reduction methods. The newest metal-artifact suppression imaging technology and future directions (ie, deep learning/artificial intelligence) in this important field will be considered.

Late Gadolinium-enhancement in cardiac magnetic resonance imaging (LGE-CMR) is the gold standard for assessing myocardial infarction (MI) size. Texture-based probability mapping (TPM) is a novel machine learning-based analysis of LGE images of myocardial injury. The ability of TPM to assess acute myocardial injury has not been determined. This proof-of-concept study aimed to determine how TPM responds to the dynamic changes in myocardial injury during one-year follow-up after a first-time revascularized acute MI. 41 patients with first-time acute ST-elevation MI and single-vessel occlusion underwent successful PCI. LGE-CMR images were obtained 2 days, 1 week, 2 months, and 1 year following MI. TPM size was compared with manual LGE-CMR based MI size, LV remodeling, and biomarkers. TPM size remained larger than MI by LGE-CMR at all time points, decreasing from 2 days to 2 months (p < 0.001) but increasing from 2 months to 1 year (p < 0.01). TPM correlated strongly with peak Troponin T (p < 0.001) and NT-proBNP (p < 0.001). At 1 week, 2 months, and 1 year, TPM showed a stronger correlation with NT-proBNP than MI size by LGE-CMR. Analyzing all collected pixels from 2 months to 1 year revealed a general increase in pixel scar probability in both the infarcted and non-infarcted regions. This proof-of-concept study suggests that TPM may offer additional insights into myocardial alterations in both infarcted and non-infarcted regions following acute MI. These findings indicate a potential role for TPM in assessing the overall myocardial response to infarction and the subsequent healing and remodeling process.

Deep learning has been widely used in research on sparse-view computed tomography (CT) image reconstruction. While sufficient training data can lead to high accuracy, collecting medical images is often challenging due to legal or ethical concerns, making it necessary to develop methods that perform well with limited data. To address this issue, we explored the use of nonmedical images for pre-training. Therefore, in this study, we investigated whether fractal images could improve the quality of sparse-view CT images, even with a reduced number of medical images. Fractal images generated by an iterated function system (IFS) were used for nonmedical images, and medical images were obtained from the CHAOS dataset. Sinograms were then generated using 36 projections in sparse-view and the images were reconstructed by filtered back-projection (FBP). FBPConvNet and WNet (first module: learning fractal images, second module: testing medical images, and third module: learning output) were used as networks. The effectiveness of pre-training was then investigated for each network. The quality of the reconstructed images was evaluated using two indices: structural similarity (SSIM) and peak signal-to-noise ratio (PSNR). The network parameters pre-trained with fractal images showed reduced artifacts compared to the network trained exclusively with medical images, resulting in improved SSIM. WNet outperformed FBPConvNet in terms of PSNR. Pre-training WNet with fractal images produced the best image quality, and the number of medical images required for main-training was reduced from 5000 to 1000 (80% reduction). Using fractal images for network training can reduce the number of medical images required for artifact reduction in sparse-view CT. Therefore, fractal images can improve accuracy even with a limited amount of training data in deep learning.

Artificial intelligence (AI) studies show promise in enhancing accuracy and efficiency in mammographic screening programs worldwide. However, its integration into clinical workflows faces several challenges, including unintended errors, the need for professional training, and ethical concerns. Notably, specific frameworks for AI imaging in breast cancer screening are still lacking. This study aims to identify the challenges associated with implementing AI in breast screening programs and to apply the Consolidated Framework for Implementation Research (CFIR) to discuss a practical governance framework for AI in this context. Three electronic databases (PubMed, Embase, and MEDLINE) were searched using combinations of the keywords "artificial intelligence," "regulation," "governance," "breast cancer," and "screening." Original studies evaluating AI in breast cancer detection or discussing challenges related to AI implementation in this setting were eligible for review. Findings were narratively synthesized and subsequently mapped directly onto the constructs within the CFIR. A total of 1240 results were retrieved, with 20 original studies ultimately included in this systematic review. The majority (n=19) focused on AI-enhanced mammography, while 1 addressed AI-enhanced ultrasound for women with dense breasts. Most studies originated from the United States (n=5) and the United Kingdom (n=4), with publication years ranging from 2019 to 2023. The quality of papers was rated as moderate to high. The key challenges identified were reproducibility, evidentiary standards, technological concerns, trust issues, as well as ethical, legal, societal concerns, and postadoption uncertainty. By aligning these findings with the CFIR constructs, action plans targeting the main challenges were incorporated into the framework, facilitating a structured approach to addressing these issues. This systematic review identifies key challenges in implementing AI in breast cancer screening, emphasizing the need for consistency, robust evidentiary standards, technological advancements, user trust, ethical frameworks, legal safeguards, and societal benefits. These findings can serve as a blueprint for policy makers, clinicians, and AI developers to collaboratively advance AI adoption in breast cancer screening. PROSPERO CRD42024553889; https://tinyurl.com/mu4nwcxt.

Chronic obstructive pulmonary disease (COPD) is a common and progressive respiratory condition characterized by persistent airflow limitation and symptoms such as dyspnea, cough, and sputum production. Acute exacerbations (AE) of COPD (AE-COPD) are key determinants of disease progression; yet, existing predictive models relying mainly on spirometric measurements, such as forced expiratory volume in 1 second, reflect only a fraction of the physiological information embedded in respiratory function tests. Recent advances in artificial intelligence (AI) have enabled more sophisticated analyses of full spirometric curves, including flow-volume loops and volume-time curves, facilitating the identification of complex patterns associated with increased exacerbation risk. This study aimed to determine whether a predictive model that integrates clinical data and spirometry images with the use of AI improves accuracy in predicting moderate-to-severe and severe AE-COPD events compared to a clinical-only model. A retrospective cohort study was conducted using COPD registry data from 2 teaching hospitals from January 2004 to December 2020. The study included a total of 10,492 COPD cases, divided into a development cohort (6870 cases) and an external validation cohort (3622 cases). The AI-enhanced model (AI-PFT-Clin) used a combination of clinical variables (eg, history of AE-COPD, dyspnea, and inhaled treatments) and spirometry image data (flow-volume loop and volume-time curves). In contrast, the Clin model used only clinical variables. The primary outcomes were moderate-to-severe and severe AE-COPD events within a year of spirometry. In the external validation cohort, the AI-PFT-Clin model outperformed the Clin model, showing an area under the receiver operating characteristic curve of 0.755 versus 0.730 (P<.05) for moderate-to-severe AE-COPD and 0.713 versus 0.675 (P<.05) for severe AE-COPD. The AI-PFT-Clin model demonstrated reliable predictive capability across subgroups, including younger patients and those without previous exacerbations. Higher AI-PFT-Clin scores correlated with elevated AE-COPD risk (adjusted hazard ratio for Q4 vs Q1: 4.21, P<.001), with sustained predictive stability over a 10-year follow-up period. The AI-PFT-Clin model, by integrating clinical data with spirometry images, offers enhanced predictive accuracy for AE-COPD events compared to a clinical-only approach. This AI-based framework facilitates the early identification of high-risk individuals through the detection of physiological abnormalities not captured by conventional metrics. The model's robust performance and long-term predictive stability suggest its potential utility in proactive COPD management and personalized intervention planning. These findings highlight the promise of incorporating advanced AI techniques into routine COPD management, particularly in populations traditionally seen as lower risk, supporting improved management of COPD through tailored patient care.